Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Hematologic Malignancies
•
Medical Oncology
•
Leukemia
•
Hematology
How do you define “induction failure” in ALL for an adult patient on hyperCVAD if goal is to proceed to transplant?
Related Questions
Would you offer intensive CNS prophylaxis to Ph negative B-ALL patients who have possible mandibular nerve involvement on MRI face?
Do you prefer to use 7+3 or CPX-351 as standard induction therapy in younger patients with AML-MRC or t-AML?
How long do you continue ATRA during induction in high risk acute promyelocytic leukemia?
How would you manage an elderly patient with mild pancytopenia who refuses bone marrow biopsy and whose flow cytometry is suggestive of CMML/MDS?
What is your approach to re-challenging BTK inhibitors for a patient who has had intolerance to several different agents?
Do complex cytogenetics have any therapeutic or prognostic relevance in CLL?
Is it possible to give Inotuzumab ozogamicin in the front line setting for an older patient with Ph- Pre-B-ALL?
What are your top takeaways in Hematologic Malignancies from ASCO 2023?
How should one approach an incidentally found T-cell gene arrangement?
Would you re challenge a CLL patient, who had good response to Zanubrutinib but contracted cryptococcal pneumonia, with another TKI?
